Jian-Hui Liang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jian-Hui Liang has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
Hong-Lei Sun
Department of Neuropharmacology, National Institute on Drug Dependence, Peking University, Beijing, People’s Republic of China
3 shared publicationsJi-Wang Zheng
Department of Neuropharmacology, National Institute on Drug Dependence, Peking University, 38 Xueyuan Road, Beijing 100083, PR China
3 shared publicationsXiang-Feng Ye
3 shared publicationsYing Lu
3 shared publicationsAndrew J. Lawrence
Howard Florey Institute and Centre for Neuroscience, University of Melbourne , Parkville, Victoria , Australia
2 shared publicationsChang-Ling Li
2 shared publications
Latest Publications
- Open Access
- 2 June 2010
- Published by Oxford University Press (OUP) in International Journal of Neuropsychopharmacology
- Vol. 14 (01) , 107-121
Transcription and protein synthesis inhibitors reduce the induction of behavioural sensitization to a single morphine exposure and regulate Hsp70 expression in the mouse nucleus accumbens
New protein synthesis has been implicated as necessary for long-lasting changes in neuronal function. Behavioural sensitization to a single exposure t
- 2 June 2010
- Published by Oxford University Press (OUP) in International Journal of Neuropsychopharmacology
- Vol. 14 (01) , 107-121
Open AccessTranscription and protein synthesis inhibitors reduce the induction of behavioural sensitization to a single morphine exposure and regulate Hsp70 expression in the mouse nucleus accumbens
New protein synthesis has been implicated as necessary for long-lasting changes in neuronal function. Behavioural sensitization to a single exposure t
- 17 December 2009
- Published by Wiley in Alcohol, Clinical and Experimental Research
- Vol. 34 (1) , 150-157
Systemic Administration of Arecoline Reduces Ethanol‐Induced Sleeping Through Activation of Central Muscarinic Receptor in Mice
Background: Epidemiological evidence of co‐use of alcohol and areca nuts suggests a potential central interaction between arecoline, a major alkaloid of areca and a muscarinic receptor agonist, and ethanol. Moreover, the central cholinergic system plays an important role in the depressant action of ethanol and barbiturates. The purpose of this study was to investigate the effects of arecoline on pentobarbital‐ and ethanol‐induced hypnosis in mice.Methods: Male ICR mice were tested for locomotor activity following acute systemic administration of ethanol alone, arecoline alone, or ethanol plus arecoline. For the loss of the righting reflex (LORR) induced by pentobarbital and ethanol, sleep latency and sleeping duration were evaluated in mice treated with arecoline alone or the combination of arecoline and scopolamine or methscopolamine.Results: Ethanol (1.0 to 3.0 g/kg, i.p.) reduced locomotor activity significantly and a declining trend was observed after treatment with arecoline (0.25 to 1.0 mg/kg, i.p.), but there were no synergistic effects of ethanol and arecoline on locomotor activity. The experiments on LORR demonstrated that arecoline (0.125 to 1.0 mg/kg, s.c.) shortened the duration of sleeping induced by ethanol (4.0 g/kg, i.p.), but not pentobarbital (45 mg/kg, i.p.). In addition, alterations of sleep latency were not obvious in both pentobarbital‐ and ethanol‐induced LORR. Statistical analyses revealed that scopolamine (centrally acting), but not methscopolamine (peripherally acting), could antagonize the effect of arecoline on the duration of ethanol‐induced LORR in mice.Conclusions: These results suggest that central muscarinic receptor is a pharmacological target for the action of arecoline to modulate ethanol‐induced hypnosis.
- 17 December 2009
- Published by Wiley in Alcohol, Clinical and Experimental Research
- Vol. 34 (1) , 150-157
Systemic Administration of Arecoline Reduces Ethanol‐Induced Sleeping Through Activation of Central Muscarinic Receptor in Mice
Background: Epidemiological evidence of co‐use of alcohol and areca nuts suggests a potential central interaction between arecoline, a major alkaloid of areca and a muscarinic receptor agonist, and ethanol. Moreover, the central cholinergic system plays an important role in the depressant action of ethanol and barbiturates. The purpose of this study was to investigate the effects of arecoline on pentobarbital‐ and ethanol‐induced hypnosis in mice.Methods: Male ICR mice were tested for locomotor activity following acute systemic administration of ethanol alone, arecoline alone, or ethanol plus arecoline. For the loss of the righting reflex (LORR) induced by pentobarbital and ethanol, sleep latency and sleeping duration were evaluated in mice treated with arecoline alone or the combination of arecoline and scopolamine or methscopolamine.Results: Ethanol (1.0 to 3.0 g/kg, i.p.) reduced locomotor activity significantly and a declining trend was observed after treatment with arecoline (0.25 to 1.0 mg/kg, i.p.), but there were no synergistic effects of ethanol and arecoline on locomotor activity. The experiments on LORR demonstrated that arecoline (0.125 to 1.0 mg/kg, s.c.) shortened the duration of sleeping induced by ethanol (4.0 g/kg, i.p.), but not pentobarbital (45 mg/kg, i.p.). In addition, alterations of sleep latency were not obvious in both pentobarbital‐ and ethanol‐induced LORR. Statistical analyses revealed that scopolamine (centrally acting), but not methscopolamine (peripherally acting), could antagonize the effect of arecoline on the duration of ethanol‐induced LORR in mice.Conclusions: These results suggest that central muscarinic receptor is a pharmacological target for the action of arecoline to modulate ethanol‐induced hypnosis.
- 1 July 2008
- Vol. 39 (3) , 221-4
[The influence of psychoactive substance on histone acetylation modification].
Psychoactive substance abuse and addiction have increasingly become severe, which are not only a serious social problem, but an important medical problem as well. Recent studies have demonstrated that the histone acetylation modification is an important epigenetic mechanism of gene regulations and plays essential roles in psychoactive substance abuse and addiction. The present review mainly presents the influence of several psychoactive substances, including cocaine, amphetamine, methamphetamine, morphine, and alcohol, on histone acetylation modification.
- 1 July 2008
- Vol. 39 (3) , 221-4
[The influence of psychoactive substance on histone acetylation modification].
Psychoactive substance abuse and addiction have increasingly become severe, which are not only a serious social problem, but an important medical problem as well. Recent studies have demonstrated that the histone acetylation modification is an important epigenetic mechanism of gene regulations and plays essential roles in psychoactive substance abuse and addiction. The present review mainly presents the influence of several psychoactive substances, including cocaine, amphetamine, methamphetamine, morphine, and alcohol, on histone acetylation modification.
- 24 January 2006
- Published by Springer Nature in Psychopharmacology
- Vol. 185 (1) , 1-10
Potentiating effect of tramadol on methamphetamine-induced behavioral sensitization in mice
Rationale Polydrug abuse is a common phenomenon in human drug addicts. Previous studies have shown that both tramadol (TRAM) and methamphetamine (METH) share the ability to modulate brain monoaminergic (dopamine, 5-hydroxytryptamine, and noradrenaline) systems that may be involved in behavioral sensitization to METH. Therefore, we hypothesized that there would be an interaction between TRAM and METH on behavioral sensitization induced by METH. Objectives To investigate whether TRAM affects METH-induced behavioral sensitization. Methods Male Kunming mice were subjected to two regimens of drugs: (1) Mice were injected with TRAM (1–16 mg/kg, i.p.) alone or a combination of TRAM and METH (1 mg/kg, i.p.) once daily for 7 days. After 7 drug-free days (on day 15), animals were challenged with the corresponding TRAM dose or METH (1 mg/kg, i.p.). On days 1, 7, and 15, locomotion was monitored in the open field test after the last injection. (2) Mice received METH (1 mg/kg, i.p.) once daily for 7 days, followed by 7 drug-free days. On day 15, a challenge of TRAM (1–16 mg/kg, i.p.) or TRAM plus METH (1 mg/kg, i.p.) was given and then locomotor activity was quantified. Results TRAM or METH challenge did not induce hyperlocomotion in mice chronically treated with TRAM, and TRAM challenge was insufficient to induce subsequent hyperlocomotion in METH-sensitized mice. However, TRAM significantly increased METH-induced hyperlocomotion. TRAM plus METH-sensitized mice showed a significantly greater hyperlocomotor response to METH challenge than METH-sensitized mice. Furthermore, TRAM (16 mg/kg, i.p.) plus METH (1 mg/kg, i.p.) challenge enhanced the sensitized locomotor response compared to METH-alone (1 mg/kg, i.p.) challenge in METH-sensitized mice. Conclusions TRAM fails to produce behavioral sensitization, and there is no apparent cross-sensitization between TRAM and METH. However, TRAM can increase METH-induced hyperlocomotion and potentiate the development and expression of behavioral sensitization to METH.
- 24 January 2006
- Published by Springer Nature in Psychopharmacology
- Vol. 185 (1) , 1-10
Potentiating effect of tramadol on methamphetamine-induced behavioral sensitization in mice
Rationale Polydrug abuse is a common phenomenon in human drug addicts. Previous studies have shown that both tramadol (TRAM) and methamphetamine (METH) share the ability to modulate brain monoaminergic (dopamine, 5-hydroxytryptamine, and noradrenaline) systems that may be involved in behavioral sensitization to METH. Therefore, we hypothesized that there would be an interaction between TRAM and METH on behavioral sensitization induced by METH. Objectives To investigate whether TRAM affects METH-induced behavioral sensitization. Methods Male Kunming mice were subjected to two regimens of drugs: (1) Mice were injected with TRAM (1–16 mg/kg, i.p.) alone or a combination of TRAM and METH (1 mg/kg, i.p.) once daily for 7 days. After 7 drug-free days (on day 15), animals were challenged with the corresponding TRAM dose or METH (1 mg/kg, i.p.). On days 1, 7, and 15, locomotion was monitored in the open field test after the last injection. (2) Mice received METH (1 mg/kg, i.p.) once daily for 7 days, followed by 7 drug-free days. On day 15, a challenge of TRAM (1–16 mg/kg, i.p.) or TRAM plus METH (1 mg/kg, i.p.) was given and then locomotor activity was quantified. Results TRAM or METH challenge did not induce hyperlocomotion in mice chronically treated with TRAM, and TRAM challenge was insufficient to induce subsequent hyperlocomotion in METH-sensitized mice. However, TRAM significantly increased METH-induced hyperlocomotion. TRAM plus METH-sensitized mice showed a significantly greater hyperlocomotor response to METH challenge than METH-sensitized mice. Furthermore, TRAM (16 mg/kg, i.p.) plus METH (1 mg/kg, i.p.) challenge enhanced the sensitized locomotor response compared to METH-alone (1 mg/kg, i.p.) challenge in METH-sensitized mice. Conclusions TRAM fails to produce behavioral sensitization, and there is no apparent cross-sensitization between TRAM and METH. However, TRAM can increase METH-induced hyperlocomotion and potentiate the development and expression of behavioral sensitization to METH.
- 18 August 2004
- Vol. 36 (4) , 361-5
Inhibition of methamphetamine-induced apoptosis by the calcium channel blocker verapamil in rat cerebellar neurons.
To study protective effects of verapamil on neurotoxicity induced by methamphetamine (MA) in rat cerebellar neuronal cells (R2 cells) and explore the possible mechanisms. MA neurotoxicity to R2 cells was examined by MTT reduction and LDH leakage assays. Using flow cytometer and agarose gel electrophoresis, apoptosis induced by MA in R2 cells was observed. The effects of verapamil on neurotoxicity and apoptosis induced by MA in R2 cells were determined. (1) Incubation of the R2 cells with MA (0.25-3.00 mmol/L) for 48 h or 60 h concentration-dependently increased the LDH content in the extra-cellular bathing medium by 48.2%-89.3% and 62.5%-97.3%, respectively. Exposure to MA elicited the apoptotic DNA peak of the R2 cells (i.e. sub-G1-peak) in a concentration- and time-dependent manner by the use of flow cytometer. Agarose gel electrophoresis showed a typical DNA laddering pattern. (2) Verapamil (0.5-5.0 micromol/L) reduced the number of dead cells and the LDH content in the extra-cellular bathing medium, ameliorated morphological changes, and inhibited apoptosis induced by MA in R2 cells. These results suggest that verapamil has a neuroprotective effect on MA-induced apoptosis, and that L-type voltage dependent calcium channel may be involved in the neurotoxitic effect of MA.
- 18 August 2004
- Vol. 36 (4) , 361-5
Inhibition of methamphetamine-induced apoptosis by the calcium channel blocker verapamil in rat cerebellar neurons.
To study protective effects of verapamil on neurotoxicity induced by methamphetamine (MA) in rat cerebellar neuronal cells (R2 cells) and explore the possible mechanisms. MA neurotoxicity to R2 cells was examined by MTT reduction and LDH leakage assays. Using flow cytometer and agarose gel electrophoresis, apoptosis induced by MA in R2 cells was observed. The effects of verapamil on neurotoxicity and apoptosis induced by MA in R2 cells were determined. (1) Incubation of the R2 cells with MA (0.25-3.00 mmol/L) for 48 h or 60 h concentration-dependently increased the LDH content in the extra-cellular bathing medium by 48.2%-89.3% and 62.5%-97.3%, respectively. Exposure to MA elicited the apoptotic DNA peak of the R2 cells (i.e. sub-G1-peak) in a concentration- and time-dependent manner by the use of flow cytometer. Agarose gel electrophoresis showed a typical DNA laddering pattern. (2) Verapamil (0.5-5.0 micromol/L) reduced the number of dead cells and the LDH content in the extra-cellular bathing medium, ameliorated morphological changes, and inhibited apoptosis induced by MA in R2 cells. These results suggest that verapamil has a neuroprotective effect on MA-induced apoptosis, and that L-type voltage dependent calcium channel may be involved in the neurotoxitic effect of MA.
- 1 May 2004
- Vol. 25 (5) , 644-50
L-type calcium channel blockers enhance 5-HTP-induced antinociception in mice.
To investigate the involvement of L-type Ca(2+) channels in antinociceptive action induced by the 5-HT precursor, 5-hydroxytryptophan (5-HTP). Female Kunming mice were treated with either 5-HTP (20-80 mg/kg, ip) alone, or the combination of 5-HTP and fluoxetine (2-8 mg/kg, ip), pargyline (15-60 mg/kg, ip), nimodipine (2.5-10 mg/kg, ip), nifedipine (2.5-10 mg/kg, ip), verapamil (2.5-10 mg/kg, ip), CaCl(2) (5-20 mmol/L, icv), or EGTA (0.5-3 mmol/L, icv) prior to the hot-plate test (55 degree, hind-paw licking latency). In addition, locomotor activity in mice treated with 5-HTP alone was measured using an ambulometer with five activity boxes. Ip injection of 5-HTP alone had no influence on the spontaneous locomotor activity, whereas dose-dependently increased the latency to licking hind-paw in the hot-plate test in mice. The inhibitory effects of 5-HTP on nociceptive response were significantly enhanced by fluoxetine in the mouse hot-plate test. At a sub-effective dose, pargyline could cause a leftward shift in the dose-response curve of 5-HTP-induced antinociception. Co-administration with 5-HTP and nimodipine, nifedipine, or verapamil obviously potentiated the antinociceptive effects elicited by 5-HTP. Interestingly, 5-HTP-induced antinociception was antagonized by CaCl(2) and enhanced by EGTA injected icv in the mouse hot-plate test. These findings suggest that systemic administration of 5-HTP may yield the antinociceptive effects, which are related to Ca(2+) influx from extracellular fluid through L-type Ca(2+) channels.
- 1 May 2004
- Vol. 25 (5) , 644-50
L-type calcium channel blockers enhance 5-HTP-induced antinociception in mice.
To investigate the involvement of L-type Ca(2+) channels in antinociceptive action induced by the 5-HT precursor, 5-hydroxytryptophan (5-HTP). Female Kunming mice were treated with either 5-HTP (20-80 mg/kg, ip) alone, or the combination of 5-HTP and fluoxetine (2-8 mg/kg, ip), pargyline (15-60 mg/kg, ip), nimodipine (2.5-10 mg/kg, ip), nifedipine (2.5-10 mg/kg, ip), verapamil (2.5-10 mg/kg, ip), CaCl(2) (5-20 mmol/L, icv), or EGTA (0.5-3 mmol/L, icv) prior to the hot-plate test (55 degree, hind-paw licking latency). In addition, locomotor activity in mice treated with 5-HTP alone was measured using an ambulometer with five activity boxes. Ip injection of 5-HTP alone had no influence on the spontaneous locomotor activity, whereas dose-dependently increased the latency to licking hind-paw in the hot-plate test in mice. The inhibitory effects of 5-HTP on nociceptive response were significantly enhanced by fluoxetine in the mouse hot-plate test. At a sub-effective dose, pargyline could cause a leftward shift in the dose-response curve of 5-HTP-induced antinociception. Co-administration with 5-HTP and nimodipine, nifedipine, or verapamil obviously potentiated the antinociceptive effects elicited by 5-HTP. Interestingly, 5-HTP-induced antinociception was antagonized by CaCl(2) and enhanced by EGTA injected icv in the mouse hot-plate test. These findings suggest that systemic administration of 5-HTP may yield the antinociceptive effects, which are related to Ca(2+) influx from extracellular fluid through L-type Ca(2+) channels.
- 21 April 2004
- Published by Elsevier in Toxicology Letters
- Vol. 150 (2) , 221-227
Nerve growth factor protects R2 cells against neurotoxicity induced by methamphetamine
- 21 April 2004
- Published by Elsevier in Toxicology Letters
- Vol. 150 (2) , 221-227
Nerve growth factor protects R2 cells against neurotoxicity induced by methamphetamine
- 3 February 2004
- Published by Elsevier in European Journal of Pharmacology
- Vol. 486 (3) , 265-271
Calmodulin inhibitor trifluoperazine attenuates the development and expression of morphine-induced conditioned place preference in rats
- 3 February 2004
- Published by Elsevier in European Journal of Pharmacology
- Vol. 486 (3) , 265-271
Calmodulin inhibitor trifluoperazine attenuates the development and expression of morphine-induced conditioned place preference in rats
- 18 February 2003
- Vol. 35 (1) , 54-60
Effects of antidepressants on the exploration, spontaneous motor activity and isolation-induced aggressiveness in mice.
To study the role of different antidepressants on exploration, spontaneous motor activity and isolation-induced aggressiveness in mice, further to discuss different mechanisms of their anti-aggression. With an aggressive model induced by isolation housing in mice, antagonism of different antidepressants against isolation-induced aggression was evaluated. In the group-housed mice given the same treatment as aggressive test, exploration and spontaneous motor activity were measured. (1) Mianserin (0.5-5 mg/kg-1), buspirone (2.5-10 mg.kg-1) and meclobemide (2.5-10 mg.kg-1) significantly inhibited the exploration in the group-housed mice, but not fluoxetine (2.5-10 mg.kg-1), imipramine (2.5-10 mg.kg-1) and DOI (0.5-2 mg.kg-1); (2) Both mianserin and buspirone, but not fluoxetine, imipramine, meclobemide and DOI, obviously reduced spontaneous motor activity; (3) Fluoxetine, miaserin, imipramine and buspirone significantly and dose-dependently antagonized isolation-induced aggressive behavior, whereas meclobemide failed to attenuate aggression. DOI dual-regulated aggressiveness in isolation mice. Our findings suggest that the effects of fluoxetine, mianserin, buspirone, imipramine, meclobemide and DOI on exploration, spontaneous motor activity and isolation-induced aggression in mice are different, which may involve different pharmacological mechanisms underlying their anti-aggression in isolation mice. 5-HT1A and 5-HT2A/2C receptors may mediate isolation-induced aggressive behavior in mice. The involvement of 5-HT receptor subtypes needs further clarification.
- 18 February 2003
- Vol. 35 (1) , 54-60
Effects of antidepressants on the exploration, spontaneous motor activity and isolation-induced aggressiveness in mice.
To study the role of different antidepressants on exploration, spontaneous motor activity and isolation-induced aggressiveness in mice, further to discuss different mechanisms of their anti-aggression. With an aggressive model induced by isolation housing in mice, antagonism of different antidepressants against isolation-induced aggression was evaluated. In the group-housed mice given the same treatment as aggressive test, exploration and spontaneous motor activity were measured. (1) Mianserin (0.5-5 mg/kg-1), buspirone (2.5-10 mg.kg-1) and meclobemide (2.5-10 mg.kg-1) significantly inhibited the exploration in the group-housed mice, but not fluoxetine (2.5-10 mg.kg-1), imipramine (2.5-10 mg.kg-1) and DOI (0.5-2 mg.kg-1); (2) Both mianserin and buspirone, but not fluoxetine, imipramine, meclobemide and DOI, obviously reduced spontaneous motor activity; (3) Fluoxetine, miaserin, imipramine and buspirone significantly and dose-dependently antagonized isolation-induced aggressive behavior, whereas meclobemide failed to attenuate aggression. DOI dual-regulated aggressiveness in isolation mice. Our findings suggest that the effects of fluoxetine, mianserin, buspirone, imipramine, meclobemide and DOI on exploration, spontaneous motor activity and isolation-induced aggression in mice are different, which may involve different pharmacological mechanisms underlying their anti-aggression in isolation mice. 5-HT1A and 5-HT2A/2C receptors may mediate isolation-induced aggressive behavior in mice. The involvement of 5-HT receptor subtypes needs further clarification.
- 28 January 2003
- Published by Springer Nature in Psychopharmacology
- Vol. 166 (3) , 276-283
Buspirone-induced antinociception is mediated by l-type calcium channels and calcium/caffeine-sensitive pools in mice
Previous studies have shown that buspirone, a partial 5-HT1A receptor agonist, produces antinociceptive effects in rats and mice; Ca2+ plays a critical role as a second messenger in mediating nociceptive transmission. 5-HT1A receptors have been proven to be coupled functionally with various types of Ca2+ channels in neurons, including N-, P/Q-, T-, or L-type. It was of interest to investigate the involvement of extracellular/intracellular Ca2+ in buspirone-induced antinociception. To determine whether central serotonergic pathways participate in the antinociceptive processes of buspirone, and investigate the involvement of Ca2+ mechanisms, particularly L-voltage-gated Ca2+ channels and Ca2+/caffeine-sensitive pools, in buspirone-induced antinociception. Antinociception was assessed using the hot-plate test (55°C, hind-paw licking latency) in mice treated with either buspirone (1.25–20 mg/kg i.p.) alone or the combination of buspirone and fluoxetine (2.5–10 mg/kg i.p.), 5-HTP (25 mg/kg i.p.), nimodipine (2.5–10 mg/kg i.p.), nifedipine (2.5–10 mg/kg i.p.), CaCl2 (25–200 nmol per mouse i.c.v.), EGTA (5–30 nmol per mouse i.c.v.), or ryanodine (0.25–2 nmol per mouse i.c.v.). Buspirone dose dependently increased the licking latency in the hot-plate test in mice. This effect of buspirone was enhanced by fluoxetine, 5-HTP, nimodipine, and nifedipine. Interestingly, central administration of Ca2+ reversed the antinociceptive effects of buspirone. In contrast to these, ryanodine or EGTA administered centrally potentiated buspirone-induced antinociception. Decreasing neuronal Ca2+ levels potentiated buspirone-induced antinociception; conversely, increasing intracellular Ca2+ abolished the antinociceptive effects of buspirone. These results suggest that Ca2+ influx from extracellular fluid and release of Ca2+ from Ca2+/caffeine-sensitive microsomal pools may be involved in buspirone-induced antinociception.
- 28 January 2003
- Published by Springer Nature in Psychopharmacology
- Vol. 166 (3) , 276-283
Buspirone-induced antinociception is mediated by l-type calcium channels and calcium/caffeine-sensitive pools in mice
Previous studies have shown that buspirone, a partial 5-HT1A receptor agonist, produces antinociceptive effects in rats and mice; Ca2+ plays a critical role as a second messenger in mediating nociceptive transmission. 5-HT1A receptors have been proven to be coupled functionally with various types of Ca2+ channels in neurons, including N-, P/Q-, T-, or L-type. It was of interest to investigate the involvement of extracellular/intracellular Ca2+ in buspirone-induced antinociception. To determine whether central serotonergic pathways participate in the antinociceptive processes of buspirone, and investigate the involvement of Ca2+ mechanisms, particularly L-voltage-gated Ca2+ channels and Ca2+/caffeine-sensitive pools, in buspirone-induced antinociception. Antinociception was assessed using the hot-plate test (55°C, hind-paw licking latency) in mice treated with either buspirone (1.25–20 mg/kg i.p.) alone or the combination of buspirone and fluoxetine (2.5–10 mg/kg i.p.), 5-HTP (25 mg/kg i.p.), nimodipine (2.5–10 mg/kg i.p.), nifedipine (2.5–10 mg/kg i.p.), CaCl2 (25–200 nmol per mouse i.c.v.), EGTA (5–30 nmol per mouse i.c.v.), or ryanodine (0.25–2 nmol per mouse i.c.v.). Buspirone dose dependently increased the licking latency in the hot-plate test in mice. This effect of buspirone was enhanced by fluoxetine, 5-HTP, nimodipine, and nifedipine. Interestingly, central administration of Ca2+ reversed the antinociceptive effects of buspirone. In contrast to these, ryanodine or EGTA administered centrally potentiated buspirone-induced antinociception. Decreasing neuronal Ca2+ levels potentiated buspirone-induced antinociception; conversely, increasing intracellular Ca2+ abolished the antinociceptive effects of buspirone. These results suggest that Ca2+ influx from extracellular fluid and release of Ca2+ from Ca2+/caffeine-sensitive microsomal pools may be involved in buspirone-induced antinociception.